Cargando…

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Liu, Shan-Lu, Saif, Linda J., Weiss, Susan R., Su, Lishan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054935/ https://www.ncbi.nlm.nih.gov/pubmed/32102621 http://dx.doi.org/10.1080/22221751.2020.1733440

Ejemplares similares

Credibility and evidence in the handling of SARS-CoV-2
por: Velilla-Jiménez, Helbert E.
Publicado: (2021)

The SARS‐CoV‐2 origin dilemma: Zoonotic transfer or laboratory leak?
por: Ruiz‐Medina, Blanca E., et al.
Publicado: (2021)

Extraordinary claims, extraordinary evidence? A discussion
por: Shiffrin, Richard M., et al.
Publicado: (2021)

Collaboration between Clinical and Academic Laboratories for Sequencing SARS-CoV-2 Genomes
por: Wang, Jeremy, et al.
Publicado: (2022)

Assessing the Reliability and Credibility of Industry Science and Scientists
por: Barrow, Craig S., et al.
Publicado: (2006)

Promoting and supporting credibility in neuroscience
por: Rousselet, Guillaume A., et al.
Publicado: (2019)

Finding the Middle Ground with the Clinical Laboratory’s Role in SARS-CoV-2 Genomic Surveillance
por: Graf, Erin H.
Publicado: (2021)

Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination
por: Hao, Pei, et al.
Publicado: (2020)

Establishing Credibility for Medical Marijuana: The Proposed Prometheus Dispensary Registry for Botanical Cannabis
por: Langley, Paul C
Publicado: (2019)

Practical problems and responses for SARS-CoV-2 laboratory testing during the COVID-19 pandemic
por: Tang, Julian W., et al.
Publicado: (2023)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

The continuing discovery on the evidence for RNA editing in SARS-CoV-2
por: Pu, Xiaoxin, et al.
Publicado: (2023)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Whose Advice is Credible? Claiming Lay Expertise in a Covid-19 Online Community
por: Au, Larry, et al.
Publicado: (2021)

Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
por: Finsterer, Josef, et al.
Publicado: (2020)

Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
por: Su, Shan, et al.
Publicado: (2021)

Pandemic Demand for SARS-CoV-2 Testing Led to Critical Supply and Workforce Shortages in U.S. Clinical and Public Health Laboratories
por: Cornish, Nancy E., et al.
Publicado: (2023)

Calling for a re‐evaluation of the data required to credibly demonstrate a dental student is safe and ready to practice
por: Dawson, L. J., et al.
Publicado: (2016)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

Ring vaccination of COVID‐19 vaccines in medium‐ and high‐risk areas of countries with low incidence of SARS‐CoV‐2 infection
por: Xu, Wei, et al.
Publicado: (2021)

Comment on: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection
por: Mantina, Namoonga M, et al.
Publicado: (2021)

The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory—SARS-CoV-2
por: Blacksell, Stuart D., et al.
Publicado: (2023)

Commentary: On the reliability of causal claims
por: Weed, Douglas L.
Publicado: (2022)

Transparent and credible practices under the microscope: a response to comments on Ihle et al.
por: Winney, Isabel S., et al.
Publicado: (2017)

Promoting Healthy Growth or Feeding Obesity? The Need for Evidence-Based Oversight of Infant Nutritional Supplement Claims
por: Lampl, Michelle, et al.
Publicado: (2016)

“Authors’ Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection”
por: Sood, Mangla, et al.
Publicado: (2021)

The Road to Hell Is Paved with Good Intentions: Why Harm–Benefit Analysis and Its Emphasis on Practical Benefit Jeopardizes the Credibility of Research
por: Grimm, Herwig, et al.
Publicado: (2017)

Updated analysis to reject the laboratory-engineering hypothesis of SARS-CoV-2
por: Wu, Fuqing
Publicado: (2023)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious?
por: Signorelli, Carlo, et al.
Publicado: (2020)

Commentary: mobile laboratories for SARS-CoV-2 diagnostics: what Europe could learn from the East African Community to assure trade in times of border closures
por: Gehre, Florian, et al.
Publicado: (2021)

Prevalence and Credibility of Nutrition and Health Claims: Policy Implications from a Case Study of Mongolian Food Labels
por: Chimedtseren, Nyamragchaa, et al.
Publicado: (2020)

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience
por: Trama, Annalisa, et al.
Publicado: (2020)

Differentiating between the possibility and probability of SARS-CoV-2 transmission associated with wastewater: empirical evidence is needed to substantiate risk
por: Ahmed, Warish, et al.
Publicado: (2021)

Prostate Cancer Claims for a Personalized Medicine
por: Lazzeri, Massimo
Publicado: (2015)

Hydroxychloroquine for COVID-19: Balancing contrasting claims
por: Horby, Peter W., et al.
Publicado: (2020)

Twisting tails exposed: the evidence for TCR conformational change
por: Levin, Susan E., et al.
Publicado: (2005)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_289nccau8n0n6g5oijck6abis3